Document is current

Any future updates will be listed below

Infusion reactions are common after high-dose carmustine in BEAM chemotherapy and are not reduced by lengthening the time of administration

Crossref DOI link: https://doi.org/10.1007/s00520-016-3399-4

Published Online: 2016-09-10

Published Print: 2017-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark